Published in J Bone Miner Res on August 01, 2011
Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol (2014) 1.41
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol (2016) 0.88
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol (2013) 0.86
1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol (2013) 0.81
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. J Am Soc Nephrol (2015) 0.80
Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat. Curr Opin Nephrol Hypertens (2015) 0.78
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats. Calcif Tissue Int (2014) 0.76
Increased risk of bone fracture among patients with urinary calculi: a nationwide longitudinal population-based study. Osteoporos Int (2014) 0.76
The relation between bone and stone formation. Calcif Tissue Int (2012) 0.75
Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest (2003) 4.04
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet (2006) 2.89
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol (2010) 2.67
Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int (2005) 2.51
NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int (2013) 1.97
A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia. Development (2005) 1.93
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol (2002) 1.91
Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol (2010) 1.54
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int (2012) 1.52
The Interaction of thiol drugs and urine pH in the treatment of cystinuria. J Urol (2012) 1.49
Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol (2014) 1.41
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int (2002) 1.25
Prevalence of hyperoxaluria after bariatric surgery. J Urol (2008) 1.22
Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone (2003) 1.12
Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice. Proc Natl Acad Sci U S A (2007) 1.10
A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol (2007) 1.10
Protein content of human apatite and brushite kidney stones: significant correlation with morphologic measures. Urol Res (2008) 1.09
Monosodium urate stones are rare, and urine pH is not low in cystinuria. Am J Kidney Dis (2013) 1.07
Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol (2012) 1.02
A visual analog scale for measuring dental fluorosis severity. J Am Dent Assoc (2005) 1.02
3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions. J Clin Invest (2011) 0.99
The effect of restrictive bariatric surgery on urinary stone risk factors. Urology (2010) 0.99
Shwachman-Diamond syndrome is associated with low-turnover osteoporosis. Bone (2007) 0.99
Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol (2005) 0.97
Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol (2002) 0.96
Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. J Bone Miner Res (2010) 0.95
Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol (2005) 0.93
Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res (2005) 0.90
Metabolic homeostasis and tissue renewal are dependent on beta1,6GlcNAc-branched N-glycans. Glycobiology (2007) 0.89
Fracture surface analysis to understand the failure mechanisms of collagen degraded bone. J Bone Miner Metab (2010) 0.88
The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol (2015) 0.86
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol (2013) 0.86
Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol (2005) 0.86
The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. J Bone Miner Res (2013) 0.86
Specificity of growth inhibitors and their cooperative effects in calcium oxalate monohydrate crystallization. J Am Chem Soc (2013) 0.84
Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol (2010) 0.84
A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria. PLoS One (2013) 0.83
Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation. J Endourol (2010) 0.83
Effect of diet orange soda on urinary lithogenicity. Urol Res (2011) 0.82
Phenotypic variation of fluoride responses between inbred strains of mice. Cells Tissues Organs (2011) 0.82
Solid freeform fabrication of porous calcium polyphosphate structures for bone substitute applications: in vivo studies. J Biomed Mater Res B Appl Biomater (2013) 0.81
1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol (2013) 0.81
Parental diabetes: the Akita mouse as a model of the effects of maternal and paternal hyperglycemia in wildtype offspring. PLoS One (2012) 0.81
Struvite urolithiasis and chronic urinary tract infection in a murine model of urinary diversion. Urology (2013) 0.80
Molecular modifiers reveal a mechanism of pathological crystal growth inhibition. Nature (2016) 0.79
Porous calcium polyphosphate bone substitutes: additive manufacturing versus conventional gravity sinter processing-effect on structure and mechanical properties. J Biomed Mater Res B Appl Biomater (2013) 0.79
First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome. J Bone Miner Res (2014) 0.79
Effect of two sports drinks on urinary lithogenicity. Urol Res (2008) 0.79
Effects of radiation and surgery on healing of femoral fractures in a rat model. J Orthop Res (2013) 0.79
Polyphosphates affect biological apatite nucleation. Cells Tissues Organs (2011) 0.79
Medicine. Stopping the stones. Science (2010) 0.79
Identification of candidate gene regions in the rat by co-localization of QTLs for bone density, size, structure and strength. PLoS One (2011) 0.78
A review of phosphate mineral nucleation in biology and geobiology. Calcif Tissue Int (2013) 0.78
A nonradioactive method for detecting phosphates and polyphosphates separated by PAGE. Electrophoresis (2007) 0.78
Relationship among MRTA, DXA, and QUS. J Clin Densitom (2004) 0.78
Weight, age and coefficients of variation in renal solute excretion. Nephron Physiol (2013) 0.77
Spaceflight affects bone formation in rhesus monkeys: a histological and cell culture study. J Appl Physiol (1985) (2002) 0.77
In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone. Bone (2012) 0.77
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats. Calcif Tissue Int (2014) 0.76
Chitosan does not reduce post-prandial urinary oxalate excretion. Urol Res (2006) 0.76
Influence of surface morphology on the colloidal and electronic behavior of conjugated polymer-silica microspheres. Langmuir (2008) 0.76
Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol (2002) 0.76
Effects of Sex on Intra-Individual Variance in Urinary Solutes in Stone-Formers Collected from a Single Clinical Laboratory. PLoS One (2013) 0.75
Variability in urinary oxalate measurements between six international laboratories. Nephrol Dial Transplant (2011) 0.75
Can OP-1 stimulate union in a rat model of pathological fracture post treatment for soft tissue sarcoma? J Orthop Res (2014) 0.75
N-acylated glucosamines for bone and joint disorders: effects of N-butyryl glucosamine on ovariectomized rat bone. Transl Res (2013) 0.75